OR WAIT null SECS
Updated employee announcements, business news, awards and recognition in the industry today.
Cambridge Biomedical, provider of customized assays for small and large molecules, biomarkers, and diagnostics, announced that Linda Robbie has been appointed as vice president of scientific
CROS NT announced that Mark Paul is being appointed to president of their North American operations. Paul has recently been serving as senior VP of Program Management for the company.
Greenphire, a global automated clinical trial payment solutions, announced that it has appointed Claudine Paccio to Chief Operations Officer.
Worldwide Clinical Trials announced the appointment of Karen Nowatkoski as VP of Clinical Operations, Site Management.
Almac Group’s announced it has been granted U.S. patent protection for its DNA Damage Response Deficiency (DDRD) assay. The patent numbers issued are 9,670,547 and 9,677,140, each titled Molecular Diagnostic Test for Cancer, and are effective until 2031.
mProve Health announced 12-month growth and the addition of 25% more new pharmaceutical companies and CROs to its client base. Additionally, the company moved into new offices in Washington, DC. This comes following 16 new hires in the past 12 months and the establishment of a UK-based team in London.
OmniComm Systems, Inc. announced that it won an $11.7 million TrialOne contract to deliver electronic data capture (EDC) software and services to a global contract research organization (CRO), with locations in the U.S. and Europe.
Sharp Clinical Services (Sharp), part of UDG Healthcare plc, has announced a £9 million ($11.5 million) investment to fund a new multiple-phase pharmaceutical manufacturing, packaging, and distribution facility in Wales.
WIRB-Copernicus IRB Group’s IBC Services group has just accomplished its 4,000th convened IBC meeting-within the U.S. and abroad. It has now administered IBCs for over 580 institutions, and reviewed more than 310 human gene transfer clinical trials and 27 bench research projects.